Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress

Brain Research

Volumn 1500, Issue , 2013, Pages 19-27

  Zhou, Ming ^a   Xu, Shengli ^a   Mi, Jiaojiao ^a   Uéda, Kenji ^a,b   Chan, Piu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Synuclein; Calpain proteolysis; Nuclear translocation; Oxidative stress; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; CALCIUM ION; CALPAIN; HYDROGEN PEROXIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL VIABILITY; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; IMMUNOREACTIVITY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; NUCLEAR TRANSLOCATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT;

ALPHA-SYNUCLEIN; ANIMALS; CALCIUM; CALPAIN; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; DIPEPTIDES; HYDROGEN PEROXIDE; MICE; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN TRANSPORT; PROTEOLYSIS; RATS;

EID: 84874654676     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.01.024     Document Type: Article

References (35)

1. K. Arima, K. Uéda, N. Sunohara, S. Hirai, Y. Izumiyama, H. Tonozuka-Uehara, and M. Kawai Immunoelectron-microscopic demonstration of NACP/a-synucleinepitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies Brain Res 808 1998 93 100 (Pubitemid 29003204)
2. 2+ uptake Neurochem. Res. 15 3 1990 313 320 (Pubitemid 20146718)
3. L. Chagniel, C. Robitaille, M. Lebel, and M. Cyr Striatal inhibition of calpains prevents levodopa-induced neurochemical changes and abnormal involuntary movements in the hemiparkinsonian rat model Neurobiol. Dis. 45 1 2012 645 655
4. B. Chera, K.E. Schaecher, A. Rocchini, S.Z. Imam, E.A. Sribnick, S.K. Ray, S.F. Ali, and N.L. Banik Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated mice Brain Res. 1006 2 2004 150 156 (Pubitemid 38393759)
5. C. Cook, C. Stetler, and L. Petrucelli Disruption of protein quality control in Parkinson's disease Cold Spring Harbor Symp. Quant. Biol. 2 5 2012 a009423
6. G.D. Crawford, W.D. Le, R. Smith, W.J. Xie, E. Stefani, and S.H. Appel A novel N18TG2x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin J. Neurosci. 12 9 1992 3392 3398
7. J.P. Daher, M. Ying, R. Banerjee, R.S. McDonald, M.D. Hahn, L. Yang, M. Flint Beal, B. Thomas, V.L. Dawson, T.M. Dawson, and D.J. Moore Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons Mol. Neurodegener. 4 2009 34
8. B.M. Dufty, L.R. Warner, S.T. Hou, S.X. Jiang, T. Gomez-Isla, K.M. Leenhouts, J.T. Oxford, M.B. Feany, E. Masliah, and T.T. Rohn Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation Am. J. Pathol. 170 5 2007 1725 1738 (Pubitemid 47339316)
9. A.R. Esteves, D.M. Arduíno, R.H. Swerdlow, C.R. Oliveira, and S.M. Cardoso Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology Neurobiol. Dis. 37 3 2010 723 730
10. M. Farrer, F. Wavrant-De Vrieze, R. Crook, L. Boles, J. Perez-Tur, J. Hardy, W.G. Johnson, J. Steele, D. Maraganore, K. Gwinn, and T. Lynch Low frequency of alpha-synuclein mutations in familial Parkinson's disease Ann. Neurol. 43 3 1998 394 397 (Pubitemid 28113605)
11. J. Goers, A.B. Manning-Bog, A.L. McCormack, I.S. Millett, S. Doniach, D.A. Di Monte, V.N. Uversky, and A.L. Fink Nuclear localization of alpha-synuclein and its interaction with histones Biochemistry 42 28 2003 8465 8471 (Pubitemid 36875412)
12. S. Grimm, A. Hoehn, K.J. Davies, and T. Grune Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease Free Radic. Res. 45 1 2011 73 88
13. L.J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, M. Mallory, J. Wong, T. Takenouchi, M. Hashimoto, and E. Masliah α-Synuclein promotes mitochondrial deficit and oxidative stress Am. J. Pathol. 157 2 2000 401 410 (Pubitemid 30627559)
14. P.H. Jensen, M.S. Nielsen, R. Jakes, C.G. Dotti, and M. Goedert Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation J. Biol. Chem. 273 41 1998 26292 26294 (Pubitemid 28471629)
15. S.J. Kim, J.Y. Sung, J.W. Um, N. Hattori, Y. Mizuno, K. Tanaka, S.R. Paik, J. Kim, and K.C. Chung Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain J. Biol. Chem. 278 43 2003 41890 41899 (Pubitemid 37310450)
16. J. Liu, M.C. Liu, and K.K. Wang Calpain in the CNS: from synaptic function to neurotoxicity Sci. Signal. 1 14 2008 re1
17. P. Łopatniuk, and J.M. Witkowski Conventional calpains and programmed cell death Acta Biochim. Pol. 58 3 2011 287 296
18. M. Lundblad, M. Decressac, B. Mattsson, and A. Björklund Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons Proc. Nat. Acad. Sci. U.S.A. 109 9 2012 3213 3219
19. L. Maroteaux, J.T. Campanelli, and R.H. Scheller Synuclein: a neuronspecific protein localized to the nucleus and presynaptic nerve terminal J. Neurosci. 8 1988 2804 2815
20. A.J. Mishizen-Eberz, E.H. Norris, B.I. Giasson, R. Hodara, H. Ischiropoulos, V.M. Lee, J.Q. Trojanowski, and D.R. Lynch Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein Chemistry 44 21 2005 7818 7829 (Pubitemid 40740765)
21. A.J. Mishizen-Eberz, R.P. Guttmann, B.I. Giasson, G.A. Day 3rd, R. Hodara, H. Ischiropoulos, V.M. Lee, J.Q. Trojanowski, and D.R. Lynch Distinct cleavage patterns of normal and pathologic forms of α-synuclein by calpain I in vitro J. Neurochem. 86 4 2003 836 847 (Pubitemid 36988796)
22. A. Mouatt-Prigent, J.O. Karlsson, Y. Agid, and E.C. Hirsch Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 73 4 1996 979 987 (Pubitemid 26194324)
23. V.M. Nemani, W. Lu, V. Berge, K. Nakamura, B. Onoa, M.K. Lee, F.A. Chaudhry, R.A. Nicoll, and R.H. Edwards Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis Neuron 65 1 2010 66 79
24. D. Olivares, X. Huang, L. Branden, N.H. Greig, and J.T. Rogers Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; The role of a putative iron-responsive element Int. J. Mol. Sci. 10 3 2009 1226 1260
25. S. Samantaray, S.K. Ray, and N.L. Banik Calpain as a potential therapeutic target in Parkinson's disease CNS Neurol. Disord. Drug Target. 7 3 2008 305 312
26. A.T. Simões, N. Gonçalves, A. Koeppen, N. Déglon, S. Kügler, C.B. Duarte, and L. Pereira de Almeida Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease Brain 135 8 2012 2428 2439
27. H. Sorimachi, S. Ishiura, and K. Suzuki Structure and physiological function of calpains Biochem. J. 328 Pt 3 1997 721 732 (Pubitemid 28005767)
28. C.G. Specht, C.M. Tigaret, G.F. Rast, A. Thalhammer, Y. Rudhard, and R. Schoepfer Subcellular localisation of recombinant alpha- and gamma-synuclein Mol. Cell. Neurosci. 28 2 2005 326 334 (Pubitemid 40202593)
29. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 6645 1997 839 840
30. M. Vila, S. Vukosavic, V. Jackson-Lewis, M. Neystat, M. Jakowec, and S. Przedborski α-Synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP J. Neurochem. 74 2 2000 721 729 (Pubitemid 30053745)
31. E.A. Waxman, J.R. Mazzulli, and B.I. Giasson Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization Biochemistry 48 40 2009 9427 9436
32. D.D. Winkler, and K. Luger The histone chaperon FACT: structural insights and mechanisms for nucleosome reorganization J. Biol. Chem. 286 21 2011 18369 18374
33. S. Xu, M. Zhou, S. Yu, Y. Cai, A. Zhang, K. Uéda, and P. Chan Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells Biochem. Biophys. Res. Commun. 342 1 2006 330 335 (Pubitemid 43247395)
34. S. Yu, X. Li, G. Liu, J. Han, C. Zhang, Y. Li, S. Xu, C. Liu, Y. Gao, H. Yang, K. Uéda, and P. Chan Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody Neurosicience 145 2 2007 539 555 (Pubitemid 46350815)
35. J.J. Zarranz, J. Alegre, J.C. Gómez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atarés, V. Llorens, E. Gomez Tortosa, T. del Ser, D.G. Muñoz, and J.G. de Yebenes The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann. Neurol. 55 2 2004 164 173 (Pubitemid 38166992)